Although we regard TBK1 as one of the most promising targets for the treatment of ALS, it is essential to emphasize the significant value of TNFSF12, RESP18, and GPX3 in ALS drug research as well. Here, TNFSF12 is linked to amyotrophic lateral sclerosis.